Octave Bioscience Awarded Valhalla Foundation Grant to Accelerate Development of the First MS Disease Progression Test

Octave Bioscience, Inc., a commercial-stage precision care company pioneering biomarker-driven solutions for multiple ...

Track Tropical Storm Octave's path as NHC eyes other disturbances

The storm is spinning in the Pacific, but continues to weaken. Meantime, the NHC is tracking three other disturbances in the ...
Nasdaq

Octave® Bioscience, Inc. Announces Real-World Study Using its Multimodal Precision Care Solution for Multiple Sclerosis Patient Management

MENLO PARK, Calif.--(BUSINESS WIRE)-- Octave® Bioscience, Inc., a leading precision care company that delivers a new standard for managing multiple sclerosis (MS) and other neurodegenerative diseases, ...
Business Wire

Octave Presents Data from Nine Company and Partner Abstracts at ACTRIMS Forum 2023

MENLO PARK, Calif.--(BUSINESS WIRE)--Octave, a leading digital health sciences company that delivers a new standard for managing multiple sclerosis (MS) and other neurodegenerative diseases, today ...
Business Wire

Octave Presents New Data at CMSC Annual Meeting 2023, Adding to Growing Evidence Supporting All Dimensions of its Comprehensive Precision Care Solution for Multiple Sclerosis

MENLO PARK, Calif.--(BUSINESS WIRE)--Octave, a leading neuroscience precision care company that delivers a new standard for managing multiple sclerosis (MS) and other neurodegenerative diseases, today ...